arrow
B

Baodong Ye

浙江中医药大学
H指数:13
被引数:581

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Validation and comparison of the molecular international prognostic scoring system (IPSS-M) and the revised international prognostic scoring system (IPSS-R) in myelodysplastic neoplasms (MDS): a retrospective study

胡明, 周敏, 沈宇, 郑智, 吴磊, 王斌, 等. 分子国际预后评分系统(IPSS-M)与国际预后评分系统修订版(IPSS-R)在骨髓增生异常肿瘤(MDS)中的验证与比较:一项回顾性研究. 血液学. (2025) 30:2479257. doi: 10.1080/16078454.2025.2479257

2025-12-312
OA
Efficacy and safety of hematopoietic stem cell transplantation vs. immunosuppressive therapy in patients with hepatitis-associated aplastic anemia: a systematic review and meta-analysis

造血干细胞移植与免疫抑制疗法在肝炎相关性再生障碍性贫血患者中的疗效与安全性:一项系统评价和荟萃分析

2025-12-310
OA
Haploidentical transplantation combined with mesenchymal stem cells co-infusion improves survival in severe aplastic anemia: a single-center retrospective study

haploidentical transplantation combined with mesenchymal stem cells co-infusion improves survival in severe aplastic anemia:一项单中心回顾性研究

2025-11-280
OAAI
Synergistic Promotion of Triple-Negative Breast Cancer Tumorigenesis and Metastasis by Oral Polystyrene Nanoplastics Exposure via Alloprevotella-Derived Glutamate and Platelet Activation

口服聚苯乙烯纳米塑料暴露通过Alloprevotella衍生的谷氨酸和血小板激活协同促进三阴性乳腺癌的肿瘤发生和转移

2025-09-240
OAAI
Reduced dose prednisone plus eltrombopag for the treatment of newly diagnosed adult primary immune thrombocytopenia: A prospective, multicentre, phase 2 clinical trial

减量剂量泼尼松联合 eltrombopag 治疗 newly diagnosed 成人 primary immune thrombocytopenia:一项前瞻性、多中心、II 期临床试验

2025-09-010
OAAI
Tetrastigma hemsleyanum Diels et Gilg polysaccharide mitigates macrophage pyroptosis and prevents acute lung injury by regulating NLRP3/Caspase-1/GSDMD signaling pathways

Tetrastigma hemsleyanum Diels et Gilg多糖通过调控NLRP3/Caspase-1/GSDMD信号通路减轻巨噬细胞焦亡并预防急性肺损伤。

2025-08-270
PRE
Comparable survival outcomes in HLA-Matched and haploidentical hematopoietic stem cell transplantation for severe aplastic anemia patients aged 40-50: A CBMTR Registry-based propensity score matching analysis over the last decade

HLA相合与半相合造血干细胞移植治疗40-50岁重型再生障碍性贫血患者的可比生存结局:一项基于CBMTR登记数据的近十年倾向性评分匹配分析

2025-07-010
PRE
Clinical characteristic of isolated thrombocytopenia in patients with bone marrow failure-related germline variants: a retrospective study from a single centre

孤立性血小板减少症在骨髓衰竭相关生殖细胞系变异患者中的临床特征:一项单中心回顾性研究

2025-06-260
OAAI
Clinical outcomes of offspring and matched unrelated donor transplants in relapsed or refractory severe aplastic anemia patients aged 40–50: a retrospective analysis from the CBMTR over the past decade

40~50岁复发或难治性严重再生障碍性贫血患者中,后代和匹配无亲缘关系供者移植的临床结局:来自CBMTR过去十年的回顾性分析

2025-06-170
PRE